TG THERAPEUTICS, INC. Stock Issued During Period, Value, Restricted Stock Award, Forfeitures
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2026-06-30 was $0.00.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2026-03-31 was $0.00.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2025-09-30 was $0.00.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for the quarter ending 2025-06-30 was $0.00.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for fiscal 2025 was $0.00.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for fiscal 2024 was $0.00.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for fiscal 2023 was $0.00.
- TG THERAPEUTICS, INC. stock issued during period, value, restricted stock award, forfeitures for fiscal 2022 was $0.00.
| Period end | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures 3 month | Stock Issued During Period, Value, Restricted Stock Award, Forfeitures 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-08-05 | |
| 2025-12-31 | $0.00 10-K · filed 2026-02-27 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-08-05 | |
| 2024-12-31 | $0.00 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-11-05 | |
| 2023-12-31 | $0.00 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $0.00 10-K · filed 2025-03-03 | |
| 2022-09-30 | $1.00K 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $1.00K 10-Q · filed 2023-11-06 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-11-06 | |
| 2021-12-31 | $0.00 10-K · filed 2024-02-29 | |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-15 | $0.00 10-K · filed 2018-03-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-16 | |
| 2011-12-31 | $1.15K 8-K/A · filed 2012-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |